prednisone has been researched along with Mucocutaneous Lymph Node Syndrome in 17 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Corticosteroid administration in Kawasaki disease (KD) is controversial but accepted as treatment for patients who do not respond to initial treatment." | 1.38 | Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression. ( Manlhiot, C; McCrindle, BW; Millar, K; Somji, Z; Yeung, RS, 2012) |
| "Kawasaki disease is recognized as a leading cause of acquired heart disease in some Western countries." | 1.35 | [Kawasaki disease: a case report from Madagascar]. ( Imbert, P; Miandrisoa, RM; Rakotomamonjy, SP; Rakotonirina, G; Rakotovao, DN; Ramanitrarivo, VL, 2008) |
| "During 1984-1992 we diagnosed Kawasaki disease in 35 patients." | 1.29 | [New therapeutic aspects in Kawasaki syndrome and personal experiences]. ( Neudorf, U, 1993) |
| "A 5-year-old girl who developed systemic lupus erythematosus 3 1/2 years after having had Kawasaki disease was found to be homozygous at both class I and class II MHC loci." | 1.27 | Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient. ( Cameron, BJ; Laxer, RM; Silverman, ED, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansoor, S | 1 |
| Sabella, C | 1 |
| Auron, M | 1 |
| Erenberg, F | 1 |
| Zeft, A | 1 |
| Rigante, D | 1 |
| Valentini, P | 1 |
| Onesimo, R | 1 |
| Angelone, DF | 1 |
| De Nisco, A | 1 |
| Bersani, G | 1 |
| Delogu, AB | 1 |
| Rakotovao, DN | 1 |
| Miandrisoa, RM | 1 |
| Ramanitrarivo, VL | 1 |
| Rakotonirina, G | 1 |
| Rakotomamonjy, SP | 1 |
| Imbert, P | 1 |
| Millar, K | 1 |
| Manlhiot, C | 1 |
| Yeung, RS | 1 |
| Somji, Z | 1 |
| McCrindle, BW | 2 |
| Gorin, R | 1 |
| Sorin, M | 1 |
| Meyer, A | 1 |
| Batisse, A | 1 |
| Toumieux, MC | 1 |
| Mozziconacci, P | 1 |
| McMahon, CJ | 1 |
| Su, JT | 1 |
| Taylor, MD | 1 |
| Krishnamurthy, R | 1 |
| Muthupillai, R | 1 |
| Kovalchin, JP | 1 |
| Chung, T | 1 |
| Vick, GW | 1 |
| Horstmann, E | 1 |
| Daweke, H | 1 |
| Zulaíca, D | 1 |
| Ruíz, M | 1 |
| Alba, A | 1 |
| Higes, A | 1 |
| Damiano, A | 1 |
| Haney, I | 1 |
| Beghetti, M | 1 |
| Gow, RM | 1 |
| Hogenesch, H | 1 |
| Snyder, PW | 1 |
| Scott-Moncrieff, JC | 1 |
| Glickman, LT | 1 |
| Felsburg, PJ | 1 |
| Neudorf, U | 1 |
| Giacomelli, R | 1 |
| Pizzuto, F | 1 |
| Cucinelli, F | 1 |
| Tonietti, G | 1 |
| Fanconi, A | 1 |
| Bodmer, P | 1 |
| Egloff, B | 1 |
| Hillyer, CD | 1 |
| Schwenn, MR | 1 |
| Fulton, DR | 1 |
| Meissner, HC | 1 |
| Berkman, EM | 1 |
| Resnick, AH | 1 |
| Esterly, NB | 1 |
| Kelly, PC | 1 |
| Pearl, WR | 1 |
| Weir, MR | 1 |
| Laxer, RM | 1 |
| Cameron, BJ | 1 |
| Silverman, ED | 1 |
3 reviews available for prednisone and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
[Mucocutaneous lymph node syndrome or Kawasaki disease].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aspirin; Child; Child, Preschool; Female; Heart Dise | 1981 |
[Immunosuppressive therapy of vasculitis: current aspects and perspectives].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Behcet Syndrome; Cyclophosphamide; Drug Therapy, | 1996 |
Vasculitis in children.
Topics: Adolescent; Adrenal Cortex Hormones; Biopsy; Child; Cytomegalovirus Infections; Diagnosis, Different | 1985 |
14 other studies available for prednisone and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Weighing Evidence and Art: A Challenging Case of Early-Onset Atypical Kawasaki Disease.
Topics: Coronary Aneurysm; Glucocorticoids; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Prednis | 2015 |
Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Diagnosis, Differential; Glucocorticoids; Humans; Infant; | 2010 |
[Kawasaki disease: a case report from Madagascar].
Topics: Adult; Developing Countries; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Madagasc | 2008 |
Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
Topics: Adolescent; Child; Child, Preschool; Coronary Aneurysm; Female; Glucocorticoids; Humans; Infant; Mal | 2012 |
[Kawasaki's cutaneo-mucosal and lymph node syndrome. A case complicated by multiple aneurysms].
Topics: Aneurysm; Angiocardiography; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aortic Aneurysm, Abdom | 1978 |
Images in cardiovascular medicine. Detection of active coronary arterial vasculitis using magnetic resonance imaging in Kawasaki disease.
Topics: Aspirin; Coronary Disease; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; | 2005 |
[Mucocutaneous lymph node syndrome (Kawasaki disease) in adults].
Topics: Adolescent; Age Factors; Aspirin; Female; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndr | 1982 |
Ventricular arrhythmia complicating Kawasaki disease.
Topics: Female; Humans; Infant; Mucocutaneous Lymph Node Syndrome; Prednisone; Tachycardia, Ventricular | 1995 |
Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Dog Diseases; Dogs; Fever; Imm | 1995 |
[New therapeutic aspects in Kawasaki syndrome and personal experiences].
Topics: Aspirin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunization, Passive; Male; | 1993 |
[Acute mucocutaneous lymph node syndrome (Kawasaki-syndrome) with fatal periarteritis nodosa of the coronary arteries. Another case from Europe].
Topics: Aorta, Thoracic; Aortic Aneurysm; Aortic Rupture; Humans; Infant; Lymphatic Diseases; Male; Mucocuta | 1978 |
Autoimmune hemolytic anemia in Kawasaki disease: a case report.
Topics: Anemia, Hemolytic, Autoimmune; Blood Transfusion; Child, Preschool; Coombs Test; Humans; Male; Mucoc | 1990 |
Infantile polyarteritis nodosa with mucocutaneous lymph node syndrome treated with long-term corticosteroids.
Topics: Aneurysm; Brachial Artery; Child; Coronary Aneurysm; Femoral Artery; Humans; Infant; Long-Term Care; | 1987 |
Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient.
Topics: Child; Female; HLA Antigens; Homozygote; Humans; Lupus Erythematosus, Systemic; Mucocutaneous Lymph | 1988 |